Director · Vor Biopharma Inc. · Vor Biopharma Inc. — Stock Option (Right to Buy)
Side
A
Value
—
Shares
3,000
Price
—
Executed
Dec 18, 2025
Disclosed
Dec 19, 2025
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Dec 18 executedDec 19, 2025 disclosed
VOR · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing0 / 15
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Levin Andrew David filed this Form 4 reporting a grant or award of VOR on Dec 18, 2025. It became public on Dec 19, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Levin Andrew Davidcik:0001867539
Issuer
Vor Biopharma Inc.cik:0001817229
Revision history · 0
No field has changed since this record was first ingested.
